These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 4506104)

  • 41. Somatomedin-like bioactivities of a growth hormone fragment on embryonic chick cartilage and cultured human fibroblasts.
    Hubbard JR; Liberti JP
    Biochim Biophys Acta; 1980 Jan; 627(2):207-14. PubMed ID: 7350924
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The interaction of proinsulin with the insulin-like growth factor-I receptor in human liver, muscle, and adipose tissue.
    Burguera B; Frank BH; DiMarchi R; Long S; Caro JF
    J Clin Endocrinol Metab; 1991 Jun; 72(6):1238-41. PubMed ID: 1851182
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification of a receptor for somatomedin-like polypeptides in human fibroblasts.
    Rechler MM; Nissley SP; Podskalny JM; Moses AC; Fryklund L
    J Clin Endocrinol Metab; 1977 May; 44(5):820-31. PubMed ID: 192752
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Steroid hormone effects on sonatomedin. I. Somatomedin action in vitro.
    Phillips LS; Herington AC; Daughaday WH
    Endocrinology; 1975 Oct; 97(4):780-6. PubMed ID: 1193005
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interaction of insulin-like growth factor II with rat chondrocytes: receptor binding, internalization, and degradation.
    Sessions CM; Emler CA; Schalch DS
    Endocrinology; 1987 May; 120(5):2108-16. PubMed ID: 2436896
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evidence for a low-molecular-weight plasma peptide which stimulates chick chondrocyte metabolism.
    Pickart L
    J Supramol Struct; 1980; 13(3):385-94. PubMed ID: 7009990
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Isolation of the insulin receptor of liver and fat-cell membranes (detergent-solubilized-( 125 I)insulin-polyethylene glycol precipitation-sephadex).
    Cuatrecasas P
    Proc Natl Acad Sci U S A; 1972 Feb; 69(2):318-22. PubMed ID: 4501116
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Somatomedin.
    Bomboy JD; Salmon WD
    Clin Orthop Relat Res; 1975 May; (108):228-40. PubMed ID: 1095277
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characterization of the insulin and somatomedin-C receptors in human placental cell membranes.
    Marshall RN; Underwood LE; Voina SJ; Foushee DB; Van Wyk JJ
    J Clin Endocrinol Metab; 1974 Aug; 39(2):283-92. PubMed ID: 4370626
    [No Abstract]   [Full Text] [Related]  

  • 50. Interaction of the monoclonal antibodies alpha IR-1 and alpha IR-3 with insulin and somatomedin-C receptors.
    Jacobs S; Cook S; Svoboda ME; Van Wyk JJ
    Endocrinology; 1986 Jan; 118(1):223-6. PubMed ID: 2416553
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Isolation and somatomedin activity of bovine growth hormone fragment 87-124.
    Liberti JP
    Biochim Biophys Acta; 1981 Jul; 675(2):239-47. PubMed ID: 7272336
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of the liver in regulating somatomedin activity: effects of streptozotocin diabetes and starvation on the synthesis and release of insulin-like growth factor and its carrier protein by the isolated perfused rat liver.
    Miller LL; Schalch DS; Draznin B
    Endocrinology; 1981 Apr; 108(4):1265-71. PubMed ID: 6258901
    [No Abstract]   [Full Text] [Related]  

  • 53. Somatomedin production by rat liver in organ culture. I. Validity of the technique. Influence of the released material on cartilage sulphation. Effects of growth hormone and insulin.
    Binoux M; Hossenlopp P; Lassarre C; Seurin D
    Acta Endocrinol (Copenh); 1980 Jan; 93(1):73-82. PubMed ID: 6986740
    [No Abstract]   [Full Text] [Related]  

  • 54. Monoiodoinsulin: demonstration of its biological activity and binding to fat cells and liver membranes.
    Freychet P; Roth J; Neville DM
    Biochem Biophys Res Commun; 1971 Apr; 43(2):400-8. PubMed ID: 5577450
    [No Abstract]   [Full Text] [Related]  

  • 55. Interaction of somatomedin-C with an antibody directed against the synthetic C-peptide region of insulin-like growth factor-I.
    Hintz RL; Liu F; Marshall LB; Chang D
    J Clin Endocrinol Metab; 1980 Feb; 50(2):405-7. PubMed ID: 6153391
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Somatomedin C/insulin-like growth factor I: simplified purification procedure and biological activities of the purified growth factor.
    Morrell DJ; Ray KP; Holder AT; Taylor AM; Blows JA; Hill DJ; Wallis M; Preece MA
    J Endocrinol; 1986 Jul; 110(1):151-8. PubMed ID: 3734674
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Response of isoalted rabbit articular and epiphyseal chondrocytes to rat liver somatomedin.
    Ash P; Francis MJ
    J Endocrinol; 1975 Jul; 66(1):71-8. PubMed ID: 1165441
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Insulin interactions with liver plasma membranes. Independence of binding of the hormone and its degradation.
    Freychet P; Kahn R; Roth J; Neville DM
    J Biol Chem; 1972 Jun; 247(12):3953-61. PubMed ID: 5033396
    [No Abstract]   [Full Text] [Related]  

  • 59. Influence of oxygen tension on somatomedin activity in vitro.
    Dehnel JM; Hamblen DL
    J Endocrinol; 1977 Mar; 72(3):361-9. PubMed ID: 856928
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Partial purification and characterization of a neutral insulin-like growth factor. Biochemical and biological properties.
    Minuto F; Barreca A; Del Monte P; Giordano G
    Biochem Int; 1986 Aug; 13(2):253-61. PubMed ID: 3768011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.